Cardiovascular diseases (CVDs) are the leading cause of death in most countries. Diabetic patients have a greater risk for CVDs. The aim of this study was to assess the prevalence and range of major CVD risk factors among diabetic patients receiving preventive and curative treatment at a diabetes clinic of Shariati Hospital based on gender and age. Four hundred eighteen diabetic participants aged 30-74 years old entered this cross-sectional study. Information about smoking habits, blood pressure, presence/absence of being under hypertension treatment, and lipid profiles was collected from each patient's medical record and SPSS version 20 was used for data analysis. The mean age of participants was 59.8 years. Smoking prevalence was 4.3%. Mean blood pressure was 121.5/79.2 mmHg. Mean total cholesterol was 152.2 mg/dl, low-density lipoprotein cholesterol(LDL-C) was 83.1 mg/dl, high-density lipoprotein cholesterol(HDL-C) was 45.4 mg/dl, and non-HDL cholesterol was 106.7 mg/dl. The prevalence of normal LDL-C was 87.3% and 77.4% in men and women, respectively (P = 0.01). Women had abnormal HDL-C levels more frequently than men (60.3% vs. 45.2%, P = 0.002). Most non-HDL levels were in normal spectrum (90.4% of males vs. 79.8% of females, P = 0.04). In individuals older than 65 years, normal values were more than abnormal ones except for females' HDL-C. The results showed that most of the patients had normal ranges for CVD risk factors and more attention for HDL control is needed. Multiple supplementary prospective studies must have been done to investigate the exact situation of risk factors' range among diabetic patients that receive preventive and curative treatment for CVD reduction.
Introduction
The most common non-communicable disease which is considered to be the leading cause of death globally in both developed and developing countries is cardiovascular diseases (CVDs) [1] . Results of one study done by Saadat and colleagues on 11,315 subjects showed that CVDs were the leading and the second most common cause of death and years of life lost (YLL), respectively [2] . Beside their mortality, these diseases cause a great economic burden and morbidity rate. Tuppin et al. reported that 15.1 € billion was spent for both inpatient and outpatient care services in either short-or longterm duration [3] . CVDs are more common in men versus premenopausal women, but the prevalence increases for females after menopause. Several risk factors have been associated with CVDs in which some of them include age, gender, hypertension (HTN), diabetes mellitus [4] , cigarette smoking, obesity, family history, diet, psychological factors, and hyperlipidemia [5] . Some of these risk factors play an important role in CVD pathogenesis wherein multiple CVD risk score This calculators like Framingham risk score (FRS) or atherosclerotic cardiovascular disease (ASCVD) risk score were designed according to them [6] . Due to vascular problems present in DM, patients suffering from this disease are more susceptible to CVDs and they are being considered as cardiovascular equivalent risk. So, identifying their risk factor prevalence and their range after receiving preventive and curative treatment for CVD reduction would be useful in making policies and preventive strategies. Several studies have been done evaluating CVD risk factors in diabetic individuals [7] . The aim of this study was to define the prevalence of those risk factors and their ranges in diabetic subjects referring to a diabetes clinic of Shariati Hospital.
Materials and Methods
This descriptive cross-sectional study was done through January till April 2014. 
Results
General characteristics of the study population are provided in Table 1 . The mean age of participants was 59.8 ± 8.7 years, and men were slightly older than women (60.5 ± 9.5 vs. 59.4 ± 8.2 years), but the dominant gender contained females (60.3%). Mean SBP and DBP of all study participants were 121.5 ± 11.7 and 79.2 ± 5.1 mmHg, respectively, which was not statistically significant. In terms of lipid indices, all levels including total cholesterol, LDL-C, HDL-C, and non-HDL were significantly lower in males compared to women. Based on gender, 49 male (29.5%) and 87 female (34.5%) participants utilized drugs for hyperlipidemia with no remarkable difference between each group. In terms of HTN treatment, 220 (87 men and 133 women) out of 418 individuals were under anti-hypertensive medication therapy, but in spite of drug usage, 26.4% (n = 23) and 30.8% (n = 41) of men and women had insignificant blood pressure levels, respectively (data not shown). Table 2 provides data on smoking and blood pressure status in the study participants. Only 4.3% of participants who were all men were positive for smoking, and the remainders (95.7%) were negative (P < 0.001). No significant association was found in terms of blood pressure treatment status, SBP, and DBP between genders. Aged-specified analysis revealed that more than half of patients older than 65 years have used anti-hypertensive agents (P < 0.001) and the DBP levels in more than 85% of them even in other age groups were under normal ranges (P = 0.02). Our findings showed that smoking and SBP were insignificantly distributed between the study population with different age groups. Table 3 provides information in terms of lipid indices among our diabetic sample size. Total cholesterol was uniformly distributed among both genders, and no significant association was found between any age groups. In terms of LDL-C, normal ranges existed more frequently in men compared to women (87.3% vs. 77.4%, respectively, P = 0.02), but this relation became insignificant after age-specified analysis. Females constituted the dominant group having abnormal HDL-C levels rather than males (60.3% vs. 45.2%, respectively, P = 0.002). Further categorization by distinct age classification could not reveal any considerable association. Likewise, abnormal non-HDL levels were significantly observed in female participants comparing to male ones with no remarkable correlation in terms of age category.
Discussion
The aim of this study was to assess the prevalence and range of major cardiovascular risk factors in diabetic patients that were under preventive and curative treatment. Although a few patients were out of normal major CVD risk factor ranges, most of our patients were in normal spectrum. However, this trend was not optimal yet. One of the most prevalent risk factors intensifying the severity of other major cardiovascular event risk factors like DM is related to dietary patterns and eating behaviors in a way that the term Bcardiodiabesity^has been introduced nowadays. Recently, a healthy diet named Mediterranean diet has been introduced and declared to be effective in terms of reducing CVD prevalence [8] . This diet mainly consists of foods containing high monounsaturated fat, low meat, and increased intake of whole grains, fruits, and vegetables [9] . Franques and colleagues conducted a systematic review investigating the effect of aforementioned diet on CVD risk factors. Their considerable results showed that Mediterranean diet played roles in prevention of both primary and secondary cardiovascular events. Also, adhering to this diet was associated with improvement in metabolic syndrome and type 2 DM in addition to healthy states mostly observed in both overweight and obese individuals. These findings signify the importance of implementing interventions in dietary factors even among DM patients in order to reduce the increasing rate of CVD mortality and morbidity [8] . Furthermore, several studies indicate the significance of these risk factors emerging especially in younger persons. For instance, results of a review Abnormal systolic blood pressure ≥ 140 mmHg, abnormal diastolic blood pressure ≥ 90 mmHg SBP systolic blood pressure, DBP diastolic blood pressure article revealed that development of major cardiovascular risk factors was related to preconception points including maternal dietary patterns or body condition which necessitates execution of interfering strategies even before conception in order to decline inheritance of risk factors by epigenetic pathways [10] . All smokers in our study belonged to the male group which was concurrent in terms of gender in multiple studies. In Mazandaran province of Iran, current smoking prevalence was 12.08% and was more common in men rather than in women and females started smoking 4 years later [11] . Our data showed that the prevalence of smoking was 4.3%, and most of the patients with age more than 65 years were nonsmoker and it was less than in several studies conducted in the normal population of Iran. In a meta-analysis done by Moosazadeh and colleagues, smoking prevalence was 6 times more in men rather than in women and was estimated 21.7 vs. 3.6% respectively [12] . Esteghamati et al. found out the prevalence of smoking in both diabetic and non-diabetic patients with acute coronary syndrome (ACS) was the same [4] . Ardeshiri et al. found out that prevalence of smoking was higher among male subjects aged 35-44 years [13] . A possible theory for our low smoking prevalence could be awareness of patients and physicians' recommendation about smoking and its effect on CVD risks. The prevalence of HTN in our study was less than 8%, and 52.4% of men and 52.8% of women used drugs for HTN treatment. Also, 65.6% of patients older than 65 years were under HTN treatment and 89.6% and 87.2% of them had SBP and DBP less than 140 and 90 mmHg, respectively. A cross-sectional study done in Tabriz by Ghaffari and colleagues revealed that HTN prevalence was 68% and it was more common in women vs. in men. Seventy-eight percent of these patients received antihypertensive drugs, and the number of females was also higher in the treatment group. That study was done on 1071 individuals aged at least 60 years, and their high HTN prevalence could be due to the effect of age [14] . Stryiewski et al. found out that hypertension was less common in men compared to postmenopausal women within the same age [15] . Mirzaei et al. mentioned that high blood pressure prevalence increased with age [16] . A low rate of HTN especially in the older ages and a significant number of HTN treatment in this study suggested effort to reduce HTN as a cardiovascular risk factor in diabetic patients. 96.4% of males and 92.5% of females and 96% of patients with age more than 65 years had total cholesterol levels less than 200 mg/dl, but our data showed that dyslipidemia was more prevalent in women rather than in men. These results were consistent with multiple studies. A cross-sectional study done by Farid et al. showed that on the total of 150 participants with DM, females had higher levels of LDL-C and cholesterol, although the latter and HDL-C levels were insignificant [17] . Data of another study done on lipid profiles of 350 diabetic patients aged 19-82 years reported that all types of dyslipidemia were more common in women rather than in men except for HDL-C in which the men were the dominant group [18] . 87.3% of male and 77.4% of females had their LDL-C levels below 100 mg/ dl. Also, 83.2% of subjects older than 65 years had levels Table 3 Distribution of properties of lipid profiles among diabetic study participants Normal total cholesterol < 200 mg/dl, abnormal total cholesterol ≥ 200 mg/dl, normal LDL-C < 100 mg/dl, abnormal LDL-C ≥ 100 mg/dl, normal HDL-C ≥ 40 mg/dl for men and ≥ 50 mg/dl for women, abnormal HDL-C < 40 mg/dl for men and < 50 mg/dl for women, normal non-HDL < 130 mg/dl, abnormal non-HDL ≥ 130 mg/dl M male, F female, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol below 100 mg/dl. Data analysis of 200 men and 200 women suffering diabetes revealed that females had significantly higher levels of cholesterol and LDL-C levels than males [19] . 54.8% of males and 39.7% of females had normal HDL-C levels. 62.1% of males older than 65 patients had HDL-C of more than 40 mg/dl, while 38.8% of females had levels more than 50 mg/dl in that age group. 90.4% and 79.8% of male and female participants had desired non-HDL levels, respectively. Alsaadi and colleagues reported that among 100 patients suffering DM and evaluated for their lipid profiles, all disturbances were more common in females vs. males, but the only significant relation was the higher mean levels of HDL in women subjects. The sample size of the mentioned study was quite small and inclusion of patients with renal or hepatic diseases and absence of assessing smoking habits were some limitations of that study [20] . Mohammadbeigi et al. demonstrated that one out of two men aged at least 25 years affected by at least one form of dyslipidemia [21] . Numerous possible theories have been postulated for explanation of these differences in females vs. males in which one of the most common of them would be different sex hormones, especially estrogen. This hormone has a protective role in CVDs, but several studies suggested that DM would disturb the action of estrogen in preventing those diseases. Type 2 DM was associated with lower HDL levels, and diabetic females had lower ranges than males. Furthermore, different obesity pattern and coagulation mechanisms might play roles in causing these differences [18] . Finally, it must be considered that in diabetic individuals HDL-C and triglyceride are better predictors of dyslipidemia and adverse consecutive events rather than LDL-C. Likewise, a similar study revealed the same point that among abnormal lipid indices HDL-C was significantly related with worsening of the nephropathy index among patients suffering from DM [22] .
This study was done on a sample of diabetic patients in which they are more susceptible to CVDs in comparison with the normal population and receive preventive and curative treatment to reduce CVD risks. Also, it assessed prevalence and spectrum of those risk factors that are parts of well-known CVD risk score calculators. Additionally, this kind of studies would be useful for assessing the efficiency of therapies and making appropriate policies for future in the prevention of CVD risk factors. Although we tried to decrease the limitations in this study, some of them were inevitable including a quite small sample size and recruiting participants from one diabetic clinic. So, other studies should be done on larger diabetic population and in different cities.
Conclusion
Our data suggested that most diabetic patients being preventively and curatively treated in this clinic had their major CVD risk factors in normal ranges and more careful HDL-C management is needed. The percentage of abnormal prevalence was quite low. Several prospective studies with a large sample size should have been done in order to evaluate the risk factor range after starting preventive and curative treatment in highrisk patients and estimate CVD risk via well-known calculators and then follow-up the patients to find out how reduction of risk factors and efficacy of calculators might be effective on preventive medicine in cardiovascular diseases.
